24 May 2013
Keywords: global, commercial, investment, stem, cell, research, stalled
Article | 17 April 2006
Investment in stem cell technology is continuing to grow, but that from the private sector has been affected by increasing ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 April 2006
17 April 2006
23 May 2013
© 2013 thepharmaletter.com